King-Denborough syndrome

A rare genetic non-dystrophic myopathy characterized by the triad of congenital myopathy, dysmorphic features and susceptibility to malignant hyperthermia. Patients present with a wide phenotypic range, including delayed motor development, muscle weakness and fatigability, ptosis and facies myopathica (with or without creatine kinase elevations), skeletal abnormalities (e.g. short stature, scoliosis, kyphosis, lumbar lordosis and pectus carinatum/excavatum), mild dysmorphic facial features (e.g. hypertelorism, down-slanting palpebral fissures, epicanthic folds, low set ears, micrognathia), webbing of the neck, cryptorchidism, and a susceptibility to malignant hyperthermia and/or rhabdomyolysis due to intensive physical strain, viral infection or statin use.

Also known as: Koussef-Nichols syndrome, King Denborough syndrome, Kousseff Nichols syndrome, Noonan like contracture myopathy hyperpyrexia, anesthetic-induced malignant hyperpyrexia in children

6 clinical trials for this condition and its sub-types, 0 tagged with King-Denborough syndrome itself.